Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets
Small Pharma shares R&D update on the expansion of its DMT-based portfolio with deuterated DMT candidate and new clinical trials...
News
TG Therapeutics Announces Scheduling of Planned Oncologic Drug Advisory Committee Meeting
FDA schedules ODAC meeting for April 22, 2022NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today...
Simply Better Brands’ No B.S. Skincare Brand Announces Sponsorship of UFC Champion Julianna Peña
The Mixed Martial Artist, dubbed the Venezuelan Vixen, will collaborate to drive brand awareness as No BS expands omni-channel Julianna...
Clade Therapeutics Announces the Appointment of Derek Hei, Ph.D., as Chief Technology Officer
Dr. Hei has spent over two decades leading manufacturing teams at biotechnology companies and has deep expertise in the cell...
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
Patient dosing underway, interim efficacy data on track for second half 2022SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- TRACON...
Oncotelic to Present New Studies on its TGF-β Program at the American Association for Cancer Research (AACR) Annual Meeting 2022
●OT-101 is Oncotelic’s RNA Therapeutic Against TGF-β●OT-101 has completed over six clinical trials against solid tumors with good efficacy●OT-101 is...
ExCellThera announces first patient treated in Phase I/II trial of ECT-001 cell therapy for pediatric patients with high risk blood cancer
MONTREAL, March 10, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and engineering company delivering molecules and...
aTyr Pharma Announces Positive End-of-Phase 2 Meeting with FDA on Efzofitimod for the Treatment of Pulmonary Sarcoidosis
Regulatory path forward supports company’s intention to initiate a planned registrational study in the third quarter of 2022.SAN DIEGO, March...
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-007 and Cetuximab Combination
ERAS-007, a potential best-in-class ERK1/2 inhibitor, is being evaluated clinically in combination with encorafenib and cetuximab in patients with BRAF...
Tempest to Present at the 32nd Annual Oppenheimer Healthcare Conference
SOUTH SAN FRANCISCO, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing...
iCAD Showcases Innovative Breast Health Solutions Platform at National Consortium of Breast Centers (NCoBC) 31st Annual Conference
iCAD’s award winning portfolio of breast health solutions to be featured at inaugural Pink Paradigm Summit, uniting clinical and advocacy...
F-star Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
Piezo Motion, Benson Engineering Join Forces to Provide OEMs with Breakthrough Technology
Piezo Motion partners with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the Southern U.S.LAKEWOOD RANCH,...
Pharmazz Inc. announces FDA clearance of an IND application for a Phase II clinical trial of centhaquine (PMZ-2010) in COVID-19 patients with ARDS
Centhaquine is a resuscitative agent free of arterial constriction that has shown improved systemic hemodynamics and clinical improvement in ARDS...
MediWound to Report Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call and Webcast on March 17, 2022
YAVNE, Israel, March 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation...
Quoin Pharmaceuticals Submits Scientific Advice Briefing Document to EMA for its Lead Asset, QRX003, for Netherton Syndrome
First Step in Development Process of QRX003 for the EUASHBURN, Va., March 10, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd....
BioVie Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
CARSON CITY, Nev., March 10, 2022 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), a clinical-stage company developing innovative drug therapies for...
Xcelerate, Inc. CEO Discusses Using AI to Advance Medical Care in Africa in Interview with SmallCapVoice.com
OTC:XCRT CEO Discusses Using AI to Advance Medical Care in Africa SmallCapVoice.com Inc. (“SCV”) announces the availability of a new...
Cocrystal Pharma Initiates Enrollment in Phase 1 Influenza A Study with Novel, Broad-Spectrum, Orally Administrated Antiviral CC-42344
BOTHELL, Wash., March 10, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces dosing of...
BioRestorative Therapies Announces Research Collaboration with Professor Tore Bengtsson to Evaluate Heat Production of its ThermoStem® Program
MELVILLE, N.Y., March 10, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage...
